





























































































































































Introduction  Measuring   the   health   of   bone   is  important   for   understanding   the  pathogenesis,   progression,   diagnosis  and  treatment  outcomes  for  fragility.  At  present  the  most  common  method  for  measuring  bone  health   in   a   clin-­‐ical  setting  is  to  assess  skeletal  mass.  The   current   gold   standard   is   dual-­‐energy   X-­‐ray   absorptiometry   (DXA)  which   models   bones   as   2D   objects  and   measures   areal   bone   mineral  density   (BMD).   However,   BMD   only  accounts   for   50%   of   bone   strength  and   the   technique   ignores   other  important   factors   such   as   cortical  geometry   and   trabecular   architec-­‐
?????? ?????? ???? ????? ????????????contributors.   Consequently   a   new  concept   of   ‘bone   quality’   has   devel-­‐oped   the   material   and   structural  basis   of   bone   strength   and   fragility.  As  yet  though,  a  suitable  non-­‐invasive  method   has   not   been   developed   for  measuring   quality   in   living   patients.  The   aim   of   this   paper   is   to   discuss  how  bone  quality  might  be  visualised,  
??????????? ???? ???????? ??? ?? ?????????setting.  
Discussion  The  most   useful   imaging   techniques  are   likely   to   be   clinical-­‐CT   and  MRI.  Both   modalities   have   been   used  successfully   to   characterise   bone  macro-­‐structure   in   3D   e.g.   volume  fraction   and   orientation.   More  recently   in   vivo   systems   with   high  
3D Imaging Bone Quality: Bench to BedsideRL  Abel1*,  M  Prime2,  A  Jin1,  JP  Cobb1,  R  Bhattacharya  2*
resolution   (~0.100–0.200  mm)   have  been   developed   that   can   capture  some  aspects  of  bone  micro-­‐architec-­‐ture.  Alternatively  3D  models  created  using  clinical-­‐CT  and  MRI  can  be  used  to   virtually   simulate   loading   on   a  computer  and  calculate  bone  mechan-­‐ical   properties.   Analysed   together  these  morphological   and  mechanical  data   sets   might   allow   clinicians   to  provide   screening   programmes   for  osteoporosis  and  calculate  individual  fracture   risk.   Especially   if   applied   as  part   of   a   holistic   approach   utilising  patient  meta-­‐data  on   risk   factors   for  metabolic   bone   disease   (e.g.   FRAX).  As   well   as   improve   primary   and  secondary   care   by   setting   treat   to  target   criteria   for   pharmacological  therapies  and  planning  surgical  inter-­‐ventions   or   following   up   treatment  outcomes.  
ConclusionIn   the   short   to   mid   term   the  expense   of   3D   imaging   and   (in   the  case  of  CT)  the  risks  associated  with  ionising  radiation  are  going  to  restrict  image  resolution.  Therefore,  in  order  to   achieve   the  goal   of  bringing  bone  quality  from  bench  to  bedside,  future  research  needs  to  be  directed  towards  better  analysis  of  3D  bone  geometry  at  sub-­‐optimal  resolution.
Introduction  
Bone  QualityResearch   into   bone   fragility   is  impeded  because  there  is  no  accurate,  precise   and   inexpensive   method   for  measuring  bone  strength—the  ability  to  resist  fracture1.  For  many  years  the  most  widely  used   technique   for  esti-­‐mating  bone  strength  has  been  densi-­‐tometry,   which   measures   bone  mineral   density   (BMD).   A   variety   of  imaging   techniques   have   been  employed  to  measure  BMD  including  
dual-­‐energy  X-­‐ray  absorptiometry  or  
DXA2,   ultrasound3   and   peripheral  computed-­‐tomography   or   pQCT4.  Originally   it   was   thought   that   bone  strength   was   almost   entirely  explained   by   density5.  However   clin-­‐ical  observations  did  not  support  the  data,   pharmaceutical   trials   revealed  that   anti-­‐resorbtive   therapies   (such  as   bisphosphonates)   reduced   frac-­‐tures   to   a   greater   degree   than  predicted  from  increases  in  BMD:  see6  and   references   therein.   This   was  because   densitometry   failed   to   take  into   account   the   importance   of  cortical   geometry   and   trabecular  architecture   for  bone  strength.  Many  research   articles   have   since   shown  that   BMD   accounts   for   only   about  40–50%7  of   the   in   vitro   compressive  strength   of   a   bone   whilst   structure  can  account  for  as  much  as  30–40%8.  Following  these  discoveries,  the  mate-­‐rial   (i.e.   density)   and   structural   (i.e.  non-­‐density)   factors   were   combined  into   a   new   understanding   of   bone  strength—termed  bone  quality,  oper-­‐
????????????????????????????????????????mechanical   basis   of   bone   strength1,9.  Quality   is  an  amalgamation  of  all   the  factors   that   determine   how  well   the  skeleton  can  resist  fracturing,  such  as  micro-­‐architecture,   accumulated  microscopic   damage,   the   quality   of  collagen,   the   size   of  mineral   crystals  and  the  rate  of  bone  turnover10.
Aims  and  objectivesAlthough  the  concept  of  bone  quality  provides   a   framework   for   summa-­‐rising   and   explaining   the   determi-­‐nants   of   bone   strength   a   metric,  method   or   protocol   for   measuring  bone   quality   has   been   elusive.   At  present  there  are  no  satisfactory  clin-­‐ical   means   to   assess   bone   quality.  Such  a  protocol  would  be  very  useful  for  screening,  monitoring  and  treating  
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bone   fragility.   Therefore,   the   aim   of  this   paper   is   to   discuss   how   bone  quality   might   be   visualised,   quanti-­‐
???????????????????????????????????????
Discussion
Imaging  bone  quality    
non-­invasivelyNon-­‐invasive  3D   imaging   techniques  can   provide   structural   information  about  bone,  beyond  simple  densitom-­‐etry11.   The   obvious   candidates   for  non-­‐invasive  imaging  of  bone  quality  are   CT12–13   and  MRI14.   CT   is   a   radio-­‐graphic  imaging  technique  that  maps  tissue  density   distribution,   as  meas-­‐ured  by  X-­‐ray  transmission  (Figure  1).  
???? ????? ????????? ??????? ???? ??????waves   to   produce   an   image   that   is  dependent   on   the   distribution   of  hydrogen  in  the  body.  Each  modality  creates   a   3D   computerised   model  made  of  voxels  (the  three-­‐dimensional  equivalent  of  a  pixel),  each  assigned  a  grey  value  based  on  the  tissues  repre-­‐sented  within.The  main  factor  limiting  the  useful-­‐ness  of  CT  and  MRI  is  spatial  resolu-­‐
tion—i.e.   the   ability   to   resolve   two  objects   of   similar   density/hydrogen  content  respectively  that  are  situated  close   to   one   another.   Resolution   is  largely  determined  by  the  size  of  the  voxels  (Figure  2).  Typically  the  reso-­‐lution  of  a  3D  scan  is  between  2  to  5  times  greater  than  the  voxel  size15.  In  
vivo  CT  scanners  produce  scans  with  smaller   voxels   than   MRI   and   there-­‐fore   have   the   potential   to   create  higher   resolution   images   of   bone  structure.  However,  the  resolution  of  CT  scans  is  also  dependent  upon  the  energy  of  the  X-­‐ray  beam  and  is  there-­‐fore  limited  by  dose  (Figure  1).  The   most   common   in   vivo   CT  systems   are   volumetric   scanners  (vQCT)  such  as  the  whole  body  scan-­‐ners  typically  found  in  hospitals.  The  smallest   voxels   are   usually   around  0.3×0.3×1.0  mm  (pixel  length  ×  width  ×   slice).   Hence   the   systems   can   be  used   to   visualise   cortical   geometry  and  trabecular  density  distribution  at  the   macro-­‐scopic   level.   Individual  trabeculae   cannot   be   visualised  because   the   elements   (<0.250   mm)  
Figure  1:   Computed  tomographic  imaging  modalities.  Clinical-­‐CT  scanners  use  lower  radiation  levels  and  can  scan  whole  bodies  but  the  resolution  is  too  low  to  visualise   tissue   level   structures.   Micro-­‐   and   nano-­‐CT   can   image   individual  trabeculae  and  even  micro-­‐cracks  respectively,  but  the  radiation  is  too  high  for  
in  vivo  scanning.  
Figure   2:   The   effect   of   voxel   size   the  accuracy   of   3D   models.   With   increasing  voxel   the   spatial   resolution   of   a   scan  decreases.   From   (A)   0.050   to   (B)   0.100  mm   the   3D   structure   can   be   clearly  visualised.   At   (C)   0.200   mm   the   larger  voxels   start   to   miss   some   features  (compare   top   left   hand   corners   of  models).   Above   (D)   0.300   and   (E)   0.400  mm  the  architecture  deteriorates.  






















































































































































disappear   inside   the   voxels.   A  phenomenon   referred   to   as   partial  volume  averaging  which  results  from  materials   of   different   density   occu-­‐pying   a   single   voxel   and   thus   being  represented   by   an   averaged   grey  value   (Figure   3).   More   recently  though   high-­‐resolution   (hrCT)  systems   have   been   developed   than  can   produce   voxels   that   are  0.090×0.090×0.200   mm   (e.g.  XtremeCT,   Scanco,   Switzerland).  The  systems  can  image  trabecular  micro-­‐architecture   but   the   trade   off   is  
?????????????????????????hrCT  systems  are   generally   restricted   to   imaging  only   the  periphery  of   the  body   such  as  wrists  and  ankles.  Likewise   hospital   MRI   scanners  typically   scan   voxels   approximately  0.5003   mm,   but   high-­‐resolution  (hrMRI)   systems   that   can   achieve  0.1003   to   0.2003  mm   are   in   develop-­‐ment16–18.   Unlike   clinical-­‐CT   systems  (which  are  limited  by  the  energy  and  therefore  the  path  length  of  the  x-­‐rays)  the  hrMRI  systems  are  not  restricted  to  peripheral  regions  of  the  body.  MRI  is  not   ideally   suited   to   imaging  bone  though   because   scanners   map   the  distribution  of  water  on  the  body  and  hard   tissues   have   a   relatively   low  water   content   (Figure   4).   Conse-­‐quently  the  MRI  signal  for  trabecular  bone   itself   is   not   visualised   as   such  and  trabeculae  appear  as  a  signal  void  surrounded   by   high-­‐intensity   fatty  bone  marrow19.  It  is  possible  to  visu-­‐alise  the  bone  more  clearly  by  simply  inverting  the  image  grey  scale.  
Quantifying  bone  quality    
non-­invasivelyCurrently   the   key   to   measuring   bone  strength  in  vivo  using  either  CT  or  MRI  is  to  get  a  handle  on  the  meaning  of  the  voxel   grey   values.   This   has   been  attempted   in   two  ways.   The   distribu-­‐tion   of   grey   values   has   been   used   to  quantify   the   macro-­‐   and   even   some  aspects   of   microstructure   that   are  correlated   with   mechanical   proper-­‐ties20.  An  alternative  approach  has  been  to   measure   mechanical   properties  
Figure   3:   Partial   volume   averaging.   A  micro-­‐CT   slice   is   comprised   of   voxels.  Partial  volume  averaging  occurs  when  materials  of  different  density  (i.e.  bone  and   air)   occupy   the   same   voxel.   The   CT   (grey)   value   assigned   to   each   voxel  
????????????????????????? ???? ?????????????????????????????????????????????????????
?????? ??? ?? ????????? ??? ???? ????? ????????? ?????????? ?????? ???? ??????? ????????
?????????????????????????????????????????????????????????????????????????????? ????like  the  dashed  line.
more  directly  by  using  3D  image  data  to  create   computer   models   for   ‘virtual’  mechanical   testing21.   Experimental  mechanical  testing  can  be  used  to  vali-­‐date   computer-­‐modelled   measure   of  mechanical  properties  (Figure  5)Baum  and  colleagues22–23  attempted  to   estimate   the   mechanical   strength  of  bone  using   low-­‐res   in  vivo  CT  and  MRI  scans  of  the  proximal  femur  and  distal   radius   respectively.   Cadaveric  femora   were   clinical-­‐CT   scanned   at  0.190×0.190×0.500   mm   voxel   size,  whilst  the  radii  were  hrMRI  imaged  at  0.156×0.156×0.300  mm.  Hence  the  in  plane  pixel  size  was  small  enough  to  
visualise   the   largest   trabeculae   but  resolution   was   ultimately   limited   by  the   slice   thickness.   In   both   studies  trabecular  macro-­‐structure  was  char-­‐acterised   by   measuring   bone  [volume]   fraction   in   3D.   Microstruc-­‐ture  was  analysed   in  2D  by  applying  traditional   histomorphometric   tech-­‐niques   such   as   the   medial   intercept  length  method  to  calculate  trabecular  thickness,   number   and   separation24.  Given   the   large   size   of   the   voxels   in  comparison   to   individual   trabeculae  the   measurements   are   usually  referred  to  as   ‘apparent’  because  the  scans   cannot   actually   resolve   the  






















































































































































strength  respectively  for  CT  and  MRI  based  data  were  apparent  trabecular  separation   (r2=0.511)   and   bone  volume   fraction   (r2=0.548),   which  were   only   moderate   correlations.  However,  by  also  including  measures  of   bone   mineral   content   collected  using   DXA   scans   (e.g.   Figure   6)   the  authors  were  able  to  improve  r2=0.760  for  CT  and  r2=0.7744  for  MRI.  Hence  apparent   trabecular   morphology  alone   was   only   able   to   explain  50–55%   of   the   variation   in   bone  strength,   but   the   inclusion   of   areal  bone  mineral  density  increased  this  to  as  much  as  77%.  These  results  suggest  that  low-­‐reso-­‐lution   (i.e.   >   0.3   mm   voxel   size)   3D  scanned   data   were   not   useful   for  predicting  bone  strength.  However,  this  may  be  due  to  the  particular  measure-­‐ment  techniques.  The  2D  histomorpho-­‐metric  measures   that  were  applied   in  2D  are  known  be  inaccurate  in  compar-­‐ison  to  3D  data,  even  when  collected  at  higher   resolution.   Micro-­‐CT   imaging  would   have   been   more   useful   for  imaging   trabecular  micro-­‐architecture  (Figure   7).   More   importantly   the  increase  in  explained  variation  with  the  inclusion   of   mineral   content   suggests  that  using  the  3D  image  data  it  was  not  possible   to   tease   apart   the   volume   of  bone   and   its   mineral   content.   Due   to  volume   averaging   the   voxels   blurred  out  the  trabeculae,  thus  it  was  possible  to  get  the  same  grey  value  representing  either  a  large  volume  of  bone  with  low  mineral   content   or   vice   versa.   Essen-­‐tially   any   successful   voxel   based  measure  might  need  to  be  able  to  sepa-­‐rate   the   effects   of   bone   volume   and  mineral   density.   This   may   only   be  achievable  at  much   smaller  voxel   size  e.g.  0.020–0.200  mm.  A  study  that  vali-­‐dates  low  resolution  measures  of  struc-­‐ture   and   density   distribution   against  high  resolution  is  therefore  required.Given   that   low-­‐resolution   analyses  of  bone  structure  alone  were  not  able  to   strongly   predict   bone   strength,   it  may  be  necessary  to  measure  mechan-­‐ical   properties   more   directly.   For  example,   using   micro-­‐CT   scans   to  
Figure  4:   MRI  cross  section  at  the  level  of  the  femoral  head,  in  which  the  bone  mass  and  structure  is  not  clearly  visible.  
Figure  5:   Femoral  head  trabecular  core  (A)  before  and  (B)  after  compression  testing.  The  rig  measures  mechanical  properties  such  as  strength  and  stiffness  which  can  be  used  to  quantify  bone  quality  and  perhaps  to  calculate  whole  bone  fracture  risk.elements  (Figure  1).  Femoral  strength  was  experimentally  measured  using  a  side   impact   test   to   simulate  a   lateral  fall   on   the   greater   trochanter.   The  forearms  were  biomechanically  tested  in   a   fall   simulation   using   a   uniaxial  testing   machine   and   the   maximum  failure   load   (i.e.   ultimate   strength)  
was   recorded.   Multiple   regression  models  were  used  to  determine  which  variables   best   predicted   bone  
?????????? ???????????? ????????????? ????trabecular   structural   measures   with  femoral   and   radial   bone   strength  amounted  to  between  r  =  0.428  and  r  =  0.740.  The  single  best  predictors  of  






















































































































































create  computer  models  of  bones  and  estimating   whole   bone   strength   by  simulating   loading.   Several  researchers   have   used   voxel   based  
??????? ???????25   modelling   to   predict  the  compressive  strength  of  bone  (see  Figure   8).   Crawford   and   colleagues26  examined  clinically-­‐CT  scanned  verte-­‐brae  with  a   large  voxel  size  of  0.6743  mm.  The  scans  were  used  to  create  3D  models   of   the   bones   that   could   be  ‘virtually’   loaded   on   the   computer  
??????? ??????? ???????? ??????????? ????
????????????????? ????? ???????????????a   mesh   that   described   variation   in  bone   volume   and   mineral   density.  Importantly   the   models   were  constructed   from   the   CT   scans   using  automated   algorithms   programmed  by   the   authors.   After   scanning,   the  ultimate   compressive   strength   of   the  vertebrae   was   measured   experimen-­‐tally   using   a   mechanical   testing   rig.  The  authors   reported   that   the  model  predicted   86%   of   the   variation   in  compressive  strength.  Thus  it  appears  as   though   computer  modelling   could  be   used   to   accurately   quantify   bone  strength   non-­‐invasively.   Fracture  loads   can   be   predicted   more   accu-­‐rately   using   3D   computer   modelling  than  DXA  data27–28.  Furthermore,  given  that   the   scans  were   very   low   resolu-­‐tion  and  therefore  quick  to  collect  and  given   that   the   mechanical   modelling  was  automated  it  is  entirely  feasible  to  use  the  method  in  a  clinical  setting.  Several   studies   have   also   used   in  
vivo? ??????????????????????????????????models  for  analysing  bone  mechanical  properties29–31.   Unlike   the   CT   based  studies   described   above   the   models  were   not   validated   using   physical  mechanical   test   data.   Since   the   voxel  sizes  were  large  (0.410  to  1.0  mm  slice  thickness)  such  a  step  would  be  neces-­‐sary.   To   date   only   one   in   vivo   MRI  based  study  has  attempted  to  corrobo-­‐rate  the  computer  modelled  mechan-­‐ical   properties,   comparing   values  measured  using  hrMRI  and  micro-­‐CT  as  the  gold  standard32.  Cadaveric  distal  tibia  were  MRI  scanned  at  0.1603  mm  voxel   size   but   the   resolution   of   the  
Figure   6:   (A)   DXA   scans   measure   (B)   bone   mineral   density   (BMD)   but   not  structure.  Since  structure  accounts  for  40–50%  of  bone  strength  the  BMD  data  is  not  highly  correlated  with  bone  mechanical  properties  or  fracture  risk.
Figure  7:   Micro-­‐CT  scans  are  excellent  for  visualising,  measuring  and  describing  trabecular   architecture  e.g.   thickness.  Micro-­‐CT   scans  of   (A)  osteoporotic   and  (B)  osteoarthritic  femoral  heads  were  compared  using  BoneJ  which  can  display  thickness  as  a  heat  map  which  is  easy  to  understand.  For  example,  note  that  the  osteoarthritic  trabeculae  are  thicker  and  better  connected  than  the  osteoporotic  elements.  






















































































































































micro-­‐CT  data  was  higher  0.2503  mm.  Trabecular  stiffness  and  elastic  moduli  (i.e.  ability  to  withstand  a  load  without  deforming)  were   computed.   Stiffness  measures   calculated   using   the   two  modalities   were   highly   correlated  (r2=0.96)   whilst   elastic   moduli   were  not   (r2=0.58).  The  authors  concluded  that  in  vivo  MRI  scans  could  probably  be  used  to  measure  some  mechanical  properties   accurately.   Further   testing  and   validation,   preferably   against  experimental  data  is  required  to  deter-­‐mine   what   information   can   be  obtained,  and  which  measures  would  be  the  most  useful.  
Applying  bone  quality  in  a    
clinical  settingIn  order  to  guide  research  into  metrics  for   bone   quality   it   is   necessary   to  
consider  the  end  clinical  uses.  A  better  understanding   of   bone   quality   could  
? ?????????? ???????????????????????????monitoring  of  pharmacological  treat-­‐ments   and   surgical   interventions   of  patients  with  fragile  bone33.  The  holy  grail  of  would  be  a  predictive  test  for  osteoporotic   fracture   risk.   For  example,   the   10-­‐year   probability   of  fracture   is   the  most   desirable  meas-­‐urement   to   determine   intervention  thresholds34.  As  yet   though  there  are  no  studies  demonstrating  prospective  fracture  risk  prediction35.  
Predicting  10-­year  fragility  
fracture  riskOsteoporotic   or   fragility   fractures  due   to   poor   bone   density   are   esti-­‐mated   to   affect   200   million   people  worldwide36  and  300,000  patients  in  
the   UK   alone37.   Yet   the   condition   is  substantially   under   diagnosed   and  under   treated38–41.   Furthermore   the  situation   is   getting   worse.   A   study  based   in   Canada   revealed   that  between  1996  and  2002,  the  number  of   patients   diagnosed  with   osteopo-­‐rosis   and   receiving   treatment  increased   from   6.1%   to   12.3%,   but  then   steadily   declined   to   5.9%   by  200842.   As   UK   life   expectancy  increases  and  the  population  ages  the  number   of   fractures   is   expected   to  rise   dramatically43.   Recently   there  has  been  move  by  the  WHO  to  set  up  tools  such  as  FRAX  (www.shef.ac.uk/FRAX/).  The  computer  driven  system  uses   algorithms   to   process   patient  
????????? ???? ??? ????????????? ???????probability   of   an   osteoporotic   frac-­‐
?????? ????????? ????? ?? ?????????????? ???family  history  and  lifestyle  as  well  as  
?????????????????????????????????????a  DXA  scan  (Figure  6).  Recent  studies  have  shown  that  although  the  system  is  reasonably  accurate  the  algorithms  tend   to   underestimate   the   risk   of  fracture  in  women,  particularly  those  in   the   most   at   risk   group   over   65  years44–45.  Improved  metrics  for  bone  quality   collected   from   3D   CT   scans  could   increase   the   predictive   power  
??? ?????? ????????????? ????????? ???mechanical   properties   based   on  
?????????????? ???? ???????????????????element   models   for   loading   bones  virtually.  
Monitoring  pharmacological  
treatmentsAftercare  in  osteoporotic  fracture  also  focuses  on  improving  bone  quality  to  prevent   further   fractures   through  various   pharmacological   means   (e.g.  calcium,  vitamin  D  and  more  recently  bisphosphonates).   After   identifying  patients   with   fragile   bones   repeat  clinical   CT   scans   could   be   used   to  monitor   disease   progression   and/or  monitor   pharmacological   treatment  outcomes.   For   example,   bisphospho-­‐nates  are  highly  effective  in  the  treat-­‐ment  of  osteoporosis.  Numerous  large  clinical  trials  have  demonstrated  their  
Figure   8:   Finite   element   analysis   is   a   computerised   version   of   mechanical  testing.  (A)  A  CT  scan  is  imaged  and  used  to  (B)  build  a  3D  computer  model  of  the   bone,   or   a   volume   of   interest  within.   (C)   The  model   is   ‘virtually’   loaded,  typically   in   compression   or   tension   and   (D)   the   stress/strain   distribution   is  
???????????






















































































































































????????? ??? ????????? ????? ??????????increasing   bone   mass   and   mineral  density   and   reducing   fracture   risk.  Consequently   bisphosphonate  therapy,  in  particular  alendronate,  has  become  the  mainstay  of  bone  fragility  treatment  since  1995.  However,  treat-­‐
????? ??????????????????? ??????????????stress  fractures  after  long-­‐term  treat-­‐ment  e.g.  5–10  years46.  At  least  in  part  due  to  accumulation,  propagation  and  merging   of   micro-­‐cracks   (Figure   9).  Many  studies  have  demonstrated  that  bone  mass  plateaus  after  3–5  years  of  therapy47,48   but,   if   treatment   ceases,  there  can  be  a  slight  loss49.  Therefore  CT   based   measures   of   fragility   frac-­‐ture  risk  could  potentially  be  used  to  set  treat  to  target  criteria  for  bisphos-­‐phonate   therapies,   monitor   progres-­‐sion,  identify  the  time  point  at  which  the  effect  of  the  drug  starts  to  slow  or  increase  stress  fracture  risk  (Figure  9)  and   implement   treatment   holidays.  Bisphosphonates   are   known   to   stay  active  in  the  body  for  up  to  7–10  years  after   treatment50   but   holidays   will  help   minimise   the   risk   of   fracture  complications.  
Informing  surgical  interventions  When  osteoporotic  fractures  do  occur  
????????? ???????? ????? ????????? ????-­‐
?????? ?????????????????????? ?????????-­‐culty   in   obtaining   secure   implant  
??????????????????????????????????????obtained   before   interventions   could  be   used   to   inform   implant   and  surgical  choices.  For  example,  neck  of  
?????? ?????????? ???? ??? ???????? ????only   if   the  bone   is   strong   enough   to  hold  the  screws.  Reduced  cortical  and  cancellous   bone  mass   decreases   the  ability   of   screw   threads   to   gain  purchase,   which   hugely   decreases  pullout   strength   and   results   in  increased  implant  failure51.  Surgeons  could  assess  a  patient’s  suitability  for  
?? ?????? ????????? ??? ?????? ??? ??????based   assessment   of   bone   quality.  When   screws   will   not   hold,   other  implant   designs   such   as   total   hips  with  acetabular  and   femoral  compo-­‐nents  are  usually  more  appropriate.  
???????????????????????????????????-­‐tion  the  components  need  to  osseoin-­‐tegrate   but   osteoporosis   alters   the  biomechanical   properties   of   bone,  making  tissue  stiffer  and  more  brittle.  Consequently  the  load  transmitted  at  the  bone-­‐implant   interface  can  often  exceed   the  strain   tolerance  of  osteo-­‐porotic  bone51  causing  micro-­‐damage  that   leads   to  micro-­‐fracture,   resorp-­‐tion   of   bone,   implant   loosening   and  subsequent   implant   failure36   which  could   happen   within   months   after  surgery.   In   the   long   term   there   is  potential   for   disease   or   patient  matched   implants   to   be   built   that  replicate   the   biomechanical   proper-­‐
??????????????????????????????????????
?????? ??? ?????? ??????? ???????? ????-­‐ysis.  In  the  short  term  there  is  a  need  to   develop   a   follow   up   protocol   to  identify  patients   that  exhibit  resorb-­‐tion  before  the  implants  fail,  perhaps  using  3D  imaging  data.  Those  patients  exhibiting   such   failure   potential  
would  need  to  be  restricted  in  terms  of  loading  the  bone-­‐implant  construct  early  and  have  earlier  repeat  surgical  intervention   and   augmentation   of  
????????? ??? ?????????? ????????? ????-­‐back  of  CT  in  this  respect   is  that  the  x-­‐rays  cannot  penetrate  metal,  which  introduces  streak  artefacts  and  noise,  blurring  the  image  and  making  anal-­‐ysis   of   bone   shape   and   mechanics  
????? ??????????? ???? ??? ????? ????? ????-­‐able   because   the   use   of   a   magnetic  
?????? ???????? ????????? ????? ?????????implants  from  being  scanned.  Clinical-­‐CT   scans   collected   preop-­‐eratively  that  describe  3D  variation  in  bone   quality   around   a   fracture   site  could   be   used   by   surgeons   to   select  the  most  appropriate  implant  and  the  locations   at   which   screws   or   nails  
??????? ??? ??????? ??? ???????? ???? ?????osseointegration.   Patients   with  enough   healthy   bone   tissue   should  
????? ????????? ????????? ?????? ???prevent  excessive  rigidity  that  may  in  
Figure  9:   Bone  micro-­‐cracks  (white  arrows)  and  are  repaired  by  remodelling.  Bisphosphonates   supress   turnover,   particularly   bone   resorption,   leading   to  increased   bone   mass.   However,   over-­‐suppression   leads   to   accumulation   of  micro-­‐cracks.   Micro-­‐cracks   can   be   imaged   using   (A)   nano-­‐CT   scans   and   (B)  thresholding   the   crack   void   (C)   in  3D.   (D)  An  FE   analysis   of   the  micro-­‐crack,  based  on   the  scan,   revealed  high  stress  concentrations  at   the   tip  which  could  cause  the  crack  to  propagate.






















































































































































turn   delay   bone   healing.   While  regions   of   poor   bone   quality   will  
???????? ????? ???????????????????? ?????locking  plates  and  screws  to  improve  
?????????? ???????? ???????? ??????? ?????been   developed   for   the   common  fragility   fractures.   The   key   change  over   conventional   devices   was   the  coupling   of   the   screw   to   the   plate,  achieved  by  conically  shaped  threads  in   the   screw  head  matching   threads  in   the  plate,  which  allows   the   screw  to  effectively  bolt   into   the  plate.  The  singular   stable   screws   prevent   load  concentration  at  a  single  bone-­‐screw  interface   by   distributing   load   more  evenly52.   Similarly   intramedullary  nails  and  other  relative  stability  tech-­‐niques,   such   as  dynamic  hip   screws,  have   been   successfully   employed   to  treat  complex  proximal  femoral  frac-­‐tures   in   the   elderly53.   Buttressing   a  fracture   by   applying   force   at   90  degrees   to   the   axis   of   a   potential  deformity   (thereby   providing   a  construct  that  resists  axial  load)  is  an  effective   method   in   metaphyseal  osteoporotic   fractures   because   it  reduces   strain   at   the   bone   implant  interface53.  
ConclusionThe   understanding   of   what   consti-­‐tutes  bone  quality  and  how   it   can  be  measured  may   lead   to   better   predic-­‐tions   of   fracture   risk,   as   well   as  improved   diagnosis,   management,  treatment,  and  monitoring  of  patients  with   fragile   bone.   Non-­‐invasive  methods  are  restricted  to  low-­‐resolu-­‐tion  whole  body  scans  or  high-­‐resolu-­‐tion   peripheral   scans   as   yet.   Clearly  research   needs   to   be   directed   to  improving   imaging   technology.   High-­‐resolution   CT   and   MRI   systems   are  already   becoming   available   on   the  market.   However,   radiation   dosage,  resolution   scan   time   and   cost   are  always  going  to  be  limiting  factors  no  matter   how   much   equipment  improves.   Accordingly   it   is   essential  
????? ???????????? ???????????????????-­‐fying   bone   quality   at   the   lowest  possible   resolution.   Even   at   sub-­‐
optimal  resolution  bone  quality  could  be  characterised  by  measuring  one  or  more   of   the   structural   and   material  aspects  of  bone,  or  by  calculating  the  mechanical   properties   more   directly  using   computer   models.   If   the   tech-­‐nique  is  going  to  translate  into  a  clin-­‐ical  setting  it  will  also  be  necessary  to  create   an   automated   computerised  system.  One  that  can  collect  a  scan  of  key   fracture   sites,   automatically  
????????? ?? ??? ??????? ???????? ???????virtually   load   the   bone   and   provide  relevant  mechanical  data  is  an  imme-­‐diate  possibility.  The  data  can  then  be  used  to  inform  primary  and  secondary  care   of   patients.   Mechanical   proper-­‐ties  could  be  entered  into  a  FRAX  (or  similar)  system,  in  place  of  BMD  meas-­‐ures.  Surgeons  could  utilise  3D  maps  of   bone   quality   distribution   to   plan  interventions,  select  implant  type  and  the  optimal  location  for  screws.  
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